What are the appropriate injection sites and dosage of onabotulinumtoxinA (Botox) for treating cervical dystonia in an adult?

OnabotulinumtoxinA for Cervical Dystonia: Injection Sites and Dosing

OnabotulinumtoxinA should be considered as an effective treatment option for cervical dystonia, with muscle selection and dosing individualized based on the specific dystonic pattern (torticollis, anterocollis, laterocollis, or retrocollis), targeting the overactive neck and shoulder muscles responsible for the abnormal posture. 1

Evidence Quality and Treatment Efficacy

The 2017 American Academy of Neurology guidelines establish that onabotulinumtoxinA has similar efficacy to incobotulinumtoxinA and should be considered for cervical dystonia treatment, though abobotulinumtoxinA and rimabotulinumtoxinB have slightly stronger evidence and "should be offered" 1. Despite this nuanced distinction in evidence levels, all FDA-approved botulinum toxin formulations are commonly used in clinical practice for cervical dystonia.

Dosing Parameters

Standard Dosing Range

• Total dose: 150-300 units per treatment session based on real-world registry data 2
• Dosing generally increases from initial to subsequent injections as treatment is optimized 2
• Treatment intervals: 12-14 weeks (median 94-97.5 days) between injections 2
• Patients naïve to botulinum toxin typically require lower initial doses 2

Specific Dosing by Clinical Context

A study of 350 patients demonstrated that doses ranged from approximately 150-175 units for cervical dystonia alone, with up to 300 units total when treating concurrent migraine (175 units for dystonia + 125 units for migraine) 3. The higher end of dosing (up to 300 units) appears safe and effective when clinically indicated.

Muscle Selection by Dystonic Pattern

Torticollis (Most Common Pattern)

Torticollis is the most frequent presentation subtype, particularly in patients with severe disease 2. Target muscles include:

• Sternocleidomastoid (SCM) - contralateral to head turn
• Splenius capitis - ipsilateral to head turn
• Levator scapulae - ipsilateral side
• Scalene muscles - as needed based on pattern

Anterocollis (Head/Neck Flexion)

Anterocollis requires a more complex approach targeting deep cervical flexors, SCM, and suprahyoid muscles 4. The specific pattern determines muscle selection:

• For head flexion: Longus capitis (requires nasal endoscopic approach for safe injection)
• For neck flexion: Longus colli
• For posterior sagittal shift: Combination approach
• Suprahyoid muscles: Often necessary for optimal control
• SCM: Frequently involved despite being a "flexor" muscle

This anterocollis subtype responds poorly without addressing all three muscle groups and benefits from a joint Neurology-ENT clinic approach 4.

Laterocollis and Retrocollis

• Laterocollis: Ipsilateral splenius capitis, levator scapulae, scalenes
• Retrocollis: Bilateral splenius capitis, semispinalis capitis, upper trapezius

Technical Considerations

Imaging Guidance

Ultrasound guidance is strongly recommended for accurate needle placement, particularly for deep cervical muscles 5. Without imaging verification, precise needle positioning cannot be confirmed, which contributes to poor treatment outcomes and side effects. Ultrasound has high capability in visualizing most neck muscles relevant to cervical dystonia treatment.

Kinematic-Guided Approach

Kinematic analysis can accelerate optimal muscle selection and minimize the need for higher doses 6. A study comparing kinematic-guided versus visual assessment-based injections showed:

• Kinematic-guided group: 28.8% reduction in TWSTRS scores by week 6
• Visual assessment group: 28.5% reduction achieved only by week 22
• Kinematic guidance resulted in faster optimization with comparable or better outcomes

Expected Outcomes

Efficacy Metrics

• 40.7-65.2% of patients with severe disease shift to moderate or mild severity after treatment 2
• Mean TWSTRS total score reduction: 28-29% (approximately 10-11 points) 3, 2
• Sustained improvements maintained across multiple treatment cycles
• 30% of patients with baseline opioid use had zero opioid fills in the 12 months following treatment initiation 7

Duration of Benefit

Long-term follow-up data demonstrates:

• Average benefit duration: 89-99 days depending on formulation 8
• OnabotulinumtoxinA specifically: 99 ± 55 days of benefit 8
• Treatment remains effective even after 25 years of repeated injections 8

Safety Profile

Common Adverse Effects

• Dysphagia (most common, particularly with higher doses or deep cervical flexor injections)
• Muscular weakness (localized to injection sites)
• Overall adverse event rate: 9% across all treatments 8
• Severe adverse events: <1% (3/739 treatments in long-term study) 8

Critical Safety Points

• No serious treatment-related adverse events in major registry studies 2
• No allergic reactions reported in 25-year follow-up 8
• Most side effects are mild to moderate and self-limiting
• Risk of dysphagia increases with anterior neck muscle injections - use caution with deep cervical flexors and reduce doses in these muscles initially

Clinical Pitfalls to Avoid

1. Undertreating anterocollis: This pattern requires injection of deep cervical flexors (longus capitis/colli) AND suprahyoid muscles, not just SCM. Failure to address all components leads to poor outcomes 4.

2. Injecting without imaging guidance: Blind injections increase risk of missing target muscles and hitting unintended structures, particularly for deep muscles 5.

3. Using fixed protocols: Torticollis is the most common pattern, but each patient requires assessment of their specific dystonic posture (pure rotation vs. combined patterns) 2.

4. Inadequate dosing in treatment-experienced patients: Doses typically need to increase from initial treatments as patterns are optimized 2.

5. Excessive dosing of anterior neck muscles: This is the primary cause of dysphagia. Start conservatively with deep cervical flexors.

Treatment Algorithm

1. Characterize the dystonic pattern: Identify primary posture (torticollis, anterocollis, laterocollis, retrocollis, or combination)
2. Determine prior botulinum toxin exposure: Naïve patients start at lower end of dosing range
3. Select target muscles based on pattern:
   • Simple torticollis: SCM, splenius capitis, levator scapulae
   • Anterocollis: Add longus capitis/colli and suprahyoid muscles
   • Complex patterns: Combine muscle groups as needed
4. Plan total dose: 150-200 units for naïve patients, up to 300 units for experienced patients with complex patterns
5. Use ultrasound guidance for accurate placement, especially deep muscles
6. Schedule follow-up at 4-6 weeks to assess response
7. Retreat at 12-14 week intervals based on symptom return